New York A02145 allows prescription labels for mifepristone, misoprostol, and their generic alternatives to include the name of the prescribing.
New York A02145 amends the education law to permit prescription labels for mifepristone, misoprostol, and their generic alternatives to include the name of the prescribing health care practice instead of the prescriber's name. This change is made at the prescriber's request. The bill modifies section 6807 to allow the dispensing health care practice's name to appear on the label, and section 6810 to allow the prescribing health care practice's name to appear on the label. The changes are effective immediately upon enactment.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.